These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6323238)

  • 21. Inhibitors of poly(ADP-ribose) synthetase enhance the cytotoxicity of 42 degrees C and 45 degrees C hyperthermia in cultured Chinese hamster cells.
    Nagle WA; Moss AJ
    Int J Radiat Biol Relat Stud Phys Chem Med; 1983 Nov; 44(5):475-81. PubMed ID: 6315616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative studies of inhibitors of ADP-ribosylation in vitro and in vivo.
    Rankin PW; Jacobson EL; Benjamin RC; Moss J; Jacobson MK
    J Biol Chem; 1989 Mar; 264(8):4312-7. PubMed ID: 2538435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effects of exposure of pancreatic islets to nicotinamide in vitro on DNA synthesis, metabolism and B-cell function.
    Sandler S; Andersson A
    Diabetologia; 1986 Mar; 29(3):199-202. PubMed ID: 2939000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of poly(ADP-ribose) synthetase in the development of insulin-dependent diabetes and islet B-cell regeneration.
    Okamoto H
    Biomed Biochim Acta; 1985; 44(1):15-20. PubMed ID: 2986610
    [No Abstract]   [Full Text] [Related]  

  • 25. Pancreatic beta-cell death, regeneration and insulin secretion: roles of poly(ADP-ribose) polymerase and cyclic ADP-ribose.
    Takasawa S; Okamoto H
    Int J Exp Diabetes Res; 2002; 3(2):79-96. PubMed ID: 11991201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High dose nicotinamide fails to prevent diabetes in BB rats.
    Hermitte L; Vialettes B; Atlef N; Payan MJ; Doll N; Scheimann A; Vague P
    Autoimmunity; 1989; 5(1-2):79-86. PubMed ID: 2535259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of poly (ADP-ribose) synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzopyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes.
    Mabley JG; Suarez-Pinzon WL; Haskó G; Salzman AL; Rabinovitch A; Kun E; Szabó C
    Br J Pharmacol; 2001 Jul; 133(6):909-19. PubMed ID: 11454665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitric oxide toxicity in islet cells involves poly(ADP-ribose) polymerase activation and concomitant NAD+ depletion.
    Radons J; Heller B; Bürkle A; Hartmann B; Rodriguez ML; Kröncke KD; Burkart V; Kolb H
    Biochem Biophys Res Commun; 1994 Mar; 199(3):1270-7. PubMed ID: 8147870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear response of pancreatic islets to interleukin-1 beta.
    Fernández-Alvarez J; Tomás C; Casamitjana R; Gomis R
    Mol Cell Endocrinol; 1994 Jul; 103(1-2):49-55. PubMed ID: 7958397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specificity of inhibitors of poly(ADP-ribose) synthesis. Effects on nucleotide metabolism in cultured cells.
    Hunting DJ; Gowans BJ; Henderson JF
    Mol Pharmacol; 1985 Aug; 28(2):200-6. PubMed ID: 2991739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influence of poly(ADP-ribose) polymerase inhibitors on some parameters of oxidative stress in blood leukocytes of rats with experimental diabetes].
    Huzyk MM; Diakun KO; Ianits'ka LV; Kuchmerovs'ka TM
    Ukr Biokhim Zh (1999); 2013; 85(1):62-70. PubMed ID: 23534291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nicotinamide-induced apoptosis in insulin producing cells is associated with cleavage of poly(ADP-ribose) polymerase.
    Saldeen J; Welsh N
    Mol Cell Endocrinol; 1998 Apr; 139(1-2):99-107. PubMed ID: 9705078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of streptozotocin- and alloxan-induced damage in rat B cells.
    Wilson GL; Patton NJ; McCord JM; Mullins DW; Mossman BT
    Diabetologia; 1984 Dec; 27(6):587-91. PubMed ID: 6241574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of the binding characteristics to and inhibitory potencies towards PARP and in vivo antidiabetogenic potencies of taurine, 3-aminobenzamide and nicotinamide.
    Pandya KG; Patel MR; Lau-Cam CA
    J Biomed Sci; 2010 Aug; 17 Suppl 1(Suppl 1):S16. PubMed ID: 20804590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ failure after zymosan-induced peritonitis in the rat.
    Cuzzocrea S; Zingarelli B; Costantino G; Sottile A; Teti D; Caputi AP
    Crit Care Med; 1999 Aug; 27(8):1517-23. PubMed ID: 10470759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model.
    Szkudelski T
    Exp Biol Med (Maywood); 2012 May; 237(5):481-90. PubMed ID: 22619373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of inhibitors of poly (ADP-ribose) polymerase on X-ray-induced potentially lethal damage repair.
    Brown DM; Evans JW; Brown JM
    Br J Cancer Suppl; 1984; 6():27-31. PubMed ID: 6320853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival and B-cell function of mouse pancreatic islets maintained in culture after concomitant exposure to streptozotocin and nicotinamide.
    Strandell E; Eizirik DL; Sandler S
    Exp Clin Endocrinol; 1989 May; 93(2-3):219-24. PubMed ID: 2528468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of cell killing by inhibitors of poly(ADP-ribose) polymerase in four rodent cell lines exposed to N-methyl-N-nitrosourea or UV light.
    Durrant LG; Boyle JM
    Chem Biol Interact; 1982 Feb; 38(3):325-38. PubMed ID: 6277522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase.
    Banasik M; Komura H; Shimoyama M; Ueda K
    J Biol Chem; 1992 Jan; 267(3):1569-75. PubMed ID: 1530940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.